Literature DB >> 18852422

Risk of admission to a nursing home among older people with visual impairment in Great Britain.

Jennifer R Evans1, Liam Smeeth, Astrid E Fletcher.   

Abstract

OBJECTIVE: To assess the risk of nursing home admission in a representative sample of older, visually impaired, community-dwelling people 75 years and older living in Great Britain.
DESIGN: Prospective study.
SETTING: General practices (n = 53). PARTICIPANTS: Participants in the Medical Research Council trial of assessment and management of older people in the community (N = 14 037). Main Outcome Measure Nursing home admission (nursing or residential care).
RESULTS: After a mean of 4 years' follow-up, 14.1% of visually impaired participants were living in nursing homes (95% confidence interval [CI], 11.9%-16.3%; age- and sex-adjusted risk ratio, 1.47 [95% CI, 1.25-1.73]). Adjusting for a wide range of confounding factors eliminated this significant association (risk ratio, 1.08 [95% CI, 0.91-1.28]).
CONCLUSIONS: The association between visual impairment and risk of nursing home admission was eliminated after controlling for a wide range of other confounding factors and comorbidities. This underlines the importance of taking a wider view of an older person's health rather than focusing on a single impairment or disability.

Entities:  

Mesh:

Year:  2008        PMID: 18852422     DOI: 10.1001/archopht.126.10.1428

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

Review 2.  Low Vision Rehabilitation, Age-Related Vision Loss, and Risk: A Critical Interpretive Synthesis.

Authors:  Debbie Laliberte Rudman; Mary Y Egan; Colleen E McGrath; Dorothy Kessler; Paula Gardner; Judy King; Christine Ceci
Journal:  Gerontologist       Date:  2016-02-17

3.  Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration.

Authors:  Rishma Gohil; Roxanne Crosby-Nwaobi; Angus Forbes; Ben Burton; Phil Hykin; Sobha Sivaprasad
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

4.  Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.

Authors:  Rishma Gohil; Roxanne Crosby-Nwaobi; Angus Forbes; Ben J Burton; Philip Hykin; Sobha Sivaprasad
Journal:  Patient Prefer Adherence       Date:  2016-05-26       Impact factor: 2.711

5.  Gender-specific associations of vision and hearing impairments with adverse health outcomes in older Japanese: a population-based cohort study.

Authors:  Takehiro Michikawa; Yuji Nishiwaki; Yuriko Kikuchi; Makiko Nakano; Satoko Iwasawa; Keiko Asakura; Ai Milojevic; Kunio Mizutari; Hideyuki Saito; Susumu Ishida; Tomonori Okamura; Toru Takebayashi
Journal:  BMC Geriatr       Date:  2009-11-22       Impact factor: 3.921

6.  Hearing ability is not a risk factor for admission to aged residential care of older persons in New Zealand.

Authors:  Philip J Schluter; Megan J McAuliffe; Deborah A Askew; Hamish A Jamieson
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.